INTRODUCTION
Neutrophilic polymorphonuclear leukocytes (PMN)' play a crucial role in host defense by engulfing and Dr. Repine is an Established Investigator of the American Heart Association.
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killing invading microorganisms. Opsonins participate in the process by facilitating ingestion of bacteria by PMN. Opsonic substances in serum include heatlabile components (primarily complement) and heatstable factors such as antibody. The specific requirements for these agents in providing optimal phagocytosis and killing of bacteria are not completely understood (1) (2) (3) (4) (5) (6) (7) (8) (9) . Considerable controversy exists regarding the necessity for early components of complement for the opsonization of bacteria (11) (12) (13) (14) (15) (16) (17) (18) . The basis for the conflicting evidence has usually been attributed to methodological differences. Published studies have employed a wide variety of phagocytic cells, test particles, and assay systems (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . A comparison of the findings from these studies indicates that these modifications of experimental design have influenced the results. Two important variables, however, have not been evaluated rigorously for their influence on phagocytosis and killing. These are the initial ratio of bacteria per neutrophil and the trace amounts of serum components remaining on the surface of washed PMN (7, 8) .
In the present investigation, cells and sera from three patients with a selective, complete deficiency of the second component of human complement (C2) were used to explore the role of C2 in opsonization. These experiments also provided an effective avenue for a detailed evaluation of the above two variables in experimental design. The results indicate that C2 is necessary for optimal bactericidal activity of normal PMN against Staphylococcus aureus, 502A but not against Escherichia coli, ON2. The findings also demonstrate the importance of the initial ratio of bacteria per neutrophil and of residual serum components on the PMN surface in the design and interpretation of such experiments. TheJournal of Clinical Investigation Volume 59 May 1977 802-809 802 METHODS This investigation was approved by the Human Volunteers Committee ofthe University of Minnesota. Blood was donated by three patients whose sera were selectively deficient in C2, and 10 normal control subjects, none of whom had infections at the time of study. The clinical diagnoses of the three patients were chronic vasculitis, systemic lupus erythematosus, and discoid lupus erythematosus, respectively. Clinical features of the first two patients have been reported in detail previously (16, 17, 19) and the third patient will be the subject of the subsequent case report.
Sera from the patients and normal subjects were obtained by venipuncture, allowed to clot on ice, rimmed, recovered by centrifugation, and then frozen in aliquots at -70°C for not more than 2 mo. Sera from five normal subjects were pooled but each patient's serum was studied individually. Complement components were measured using functional hemolytic and radial immunodiffusion assays (20) (21) (22) . Complement profiles of fresh serum were comparable to serum which was frozen and thawed once before use. For some experiments total measurable hemolytic activity was destroyed by heating at 560C for 30 min. In other studies the assayable hemolytic activity of C2-deficient serum was restored by the addition of 2,500 U of C2 reagent (Cordis Laboratories, Miami, Fla.). To characterize the purity of this C2 reagent, the following studies were performed: purified C2 was isolated from the diisopropyl fluorophosphate-treated pseudoglobulin fraction of human serum by carboxymethylcellulose chromatography and Pevikon block electrophoresis (Mercer Consolidated Corp., Yonkers, N. Y.) (23) . Fractions containing C2 activity were pooled, concentrated, and then injected in complete Freund's adjuvant into rabbits. Samples of blood from rabbits were applied to a Sepharose-4B immunoadsorbent column (Pharmacia Fine Chemicals, Piscatawa, N. J.) comprised of C2-deficient human serum to purify the antiserum. Monospecificity of the C2 antiserum was verified by a reaction of complete identity with a reference C2 antiserum (kindly supplied by Dr. Margaret Polley, Cornell University) in immunodiffusion against purified C2, by the presence of a single precipitin line against whole human serum in immunoelectrophoresis, and by the absence of a precipitin line in immunodiffusion against the sera of the three individuals totally deficient for C2. Double diffusion Ouchterlony analysis using normal serum, C2 reagent, and C2 antiserum demonstrated that the C2 antiserum reacted only with C2 ( Fig. 1) .
Neutrophils and bacteria were prepared (24) and bactericidal activity was measured using methods previously described in detail (25) . Briefly, 4 x 106 washed PMN from a patient or normal subject were combined with washed, stationary phase S. aureus, 502A or E. coli, ON2 adjusted to yield ratios of 1.25 or 50 bacteria per neutrophil in 1.0 ml Hanks' balanced salt solution (HBSS) with or without a known percentage of serum. Microsamples of the test mixtures were taken immediately and after incubation for 60 min at 37°C. The samples were diluted, osmotically lysed, sonicated, and then plated in agar. After a 48-h period of growth, the number of bacterial colonies on each plate was counted using an automatic colony counter (3M Co. St. Paul, Minn., model 620). Counts at 0 and 60 min were used to calculate the observed initial ratio of bacteria per neutrophil and the percentage of the initial bacterial inoculum which was killed. Each determination is the average of triplicate samplings from duplicate tubes. Controls to determine the rate of bacterial growth FIGURE 1 Double diffusion Ouchterlony analysis demonstrated that the C2 antiserum reacts only with purified C2: C2-deficient serum (a), normal human serum (b), Cordis C2 reagent (c), veronal buffer (d), and rabbit anti-human C2 (e). and (or) the bactericidal effect of serum were run in parallel with each test.
The standard preparation of PMN for these studies consisted of two washes with HBSS and resuspension in a third aliquot of HBSS. The cells were separated from serum and the HBSS washes by careful decantation after centrifugation at 140 g for 12 min at room temperature. In one group of experiments, matched samples of PMN were tested for bactericidal capacity after one to four washes. In another group of studies, PMN were similarly washed using glucosegelatin-veronal buffer with calcium and magnesium. The undiluted supernates from these latter washes were tested for C2 activity by standard hemolytic and modified rat assays (21, 26) . Effective molecules of C2 per milliliter, and microgram quantities of C2 protein per milliliter were calculated by previously described methods (27, 28) .
RESULTS
In this group of studies, a carefully controlled assay of PMN bactericidal function was used to examine the opsonic potency of sera from C2-deficient patients and control subjects. The details of this method have been presented previously and form the basis for the following experiments (25) . The method relies on the bacteria being in lag-phase during the period of incubation with PMN. This was assured by running with each experiment a pair of control tubes which contained all components of the test mixture including serum but excluding the PMN. These serum control tubes were sampled to determine the degree of bacterial replication and (or) possible bactericidal action of the media. The bacterial counts in the control tubes for the following experiments increased 18+8% (SD) from the initial inoculum over the 60-min incubation for S. aureus and 35+16% for E. coli. Supernates removed from PMN-S. aureus mixtures after incubation were not bactericidal.
The levels of complement components in the sera of the three patients were all normal except for C2 which was undetectable in all three (Table I) . Table  II . In all of these experiments, PMN were twicewashed ans resuspended in HBSS. Where serum was added to the phagocytic system, 4% was used for all 1.25:1 studies and 8% was used in the 50:1 studies. These levels were chosen to provide the minimum concentration of serum consistent with optimal opsonization (Fig. 2) . PMN from the patients were tested with autologous serum where the tables indicate replacement with C2-deficient serum.
At the ratio of 1.25 bacteria per neutrophil, twicewashed control PMN killed only about halfthe number of S. aureus in C2-deficient sera as in normal pooled serum. However, C2-deficient serum supported a 10-fold increase in killing of S. aureus by PMN over that seen without replacement of serum. When the C2-deficient sera were reconstituted with 2,500 U of C2 reagent per milliliter, the bactericidal capacity of the control cells returned to normal. In contrast, at 50:1 C2-deficient sera supported bactericidal activity of control PMN as well as normal pooled serum. Addition of purified C2 did not significantly increase bactericidal activity at 50:1.
The specific role of C2 in the opsonization process was confirmed by studies using a well-characterized, purified C2 antiserum. Normal serum treated with monospecific C2 antiserum did not promote optimal opsonization and killing ofS. aureus by PMN. Furthermore, addition of C2 reagent that had been pretreated with C2 antiserum to the patient's C2-deficient serum 804
J. E. Repine, C. C. Clawson, and P. S. Friend Bactericidal activity of PMN from C2-deficient patients. Parallel examinations of the function of twice-washed PMN from the three C2-deficient patients were made (Table II) . At the lower bacterial ratio, the patients' cells had significantly depressed bactericidal function only with autologous serum. The depressed bactericidal activity was not improved by increasing the percentage of serum added (Fig. 3) . After the C2-deficient sera were reconstituted with purified C2 reagent, the function of PMN from the patients was normal (Table II) . In normal pooled serum at the low ratio of S. aureus, the patients' PMN killed a normal percentage of the bacteria.
When the patients' PMN were challenged with 50 S. aureus per cell, a similar pattern of bactericidal activity was noted. Killing of S. aureus was significantly depressed for each of the three populations of these PMN when tested with autologous serum.
Again reconstitution of the C2-deficient sera with C2 reagent restored bactericidal function to normal. The mean percentage of S. aureus killed (27.2+3.3 ,  Table II ) at the high ratio by patients' PMN in normal pooled serum requires clarification. In this and other studies, normal PMN tested at 50:1 have killed 42+20 (2 SD) or from 22 to 62% of the S. aureus presented. None of the three mean values for killing of bacteria of PMN from the individual patients fell below these limits although as a group they tended to be in the lower normal region. Therefore, taken in toto, these several examinations must be interpreted to reveal no intrinsic defect in the ability of the patients' PMN to kill S. aureus in vitro.
Results of studies without added serum, with heated pooled serum, or with heated C2-deficient sera are also given in Table II C2-deficient sera supported no more killing of bacteria by PMN from controls or patients than when no serum was replaced in the system. This suggests that heat-stable components present in normal serum interacted differently with twice-washed control cells than with the patients' washed PMN. The reason for this is explained by the following set of experiments.
Influence of trace amounts of serum components remaining on the surface of PMN from control subjects. The studies reported above were all carried out with PMN prepared by a standard doublewashing procedure. Analysis of the data suggested that some of the findings could be explained by residual complement components on the surface of the twice- washed neutrophils. These were principally the observations that the patients' PMN, although having normal bactericidal capacity under conditions of optimal opsonization, killed fewer S. aureus than control PMN under suboptimal opsonic conditions (Table II) .
To evaluate this possibility, control PMN were tested for bactericidal function after each of a series of four washes with HBSS (Fig. 4) . The PMN were fully viable after each wash and showed stable levels of bactericidal activity at both ratios when the final media contained the appropriate concentration of normal pooled serum (Fig. 4) . If C2-deficient serum was used for replacement in the incubation media for either test ratio, the killing of S. aureus fell to less than 10% when control PMN had been triply-washed. These levels are comparable to the low degree of killing of bacteria shown above (Table II) when the patients' PMN were tested with autologous C2-deficient sera. Further, the levels of killing by control cells after the third wash were not significantly higher with C2-deficient serum than without replacement of serum. Results of bactericidal assays after a fourth wash were all comparable to those after the third wash; therefore the effect of further washes was not studied. These observations indicate that the discrepancies between bactericidal functions of twicewashed PMN from controls and patients under suboptimal conditions of opsonization were due to a residual serum factor associated with the control cells. This factor may be presumed to be C2 since this is the only identifiable variable between control and patient cells, and purified C2 provided full correction of function for the patients' PMN.
When the control cells were given a third wash (Fig. 4) , the bactericidal capacity in the face of a 50:1 challenge without added serum fell to less than 5%. This latter value was not a significantly higher level of bactericidal activity than at 1.25:1. These findings indicate the importance of opsonic factors associated with the cell surface in the assessment of bactericidal function.
Supernates from the sequential washes of the control cells were tested for C2 activity using a standard hemolytic assay and the more sensitive modified rat assay (Table III) . C2 activity was present in significant levels in the third supernate by both assay procedures. This represents the C2 which could be removed from twice-washed cells by a third HBSS wash. Therefore, at least this amount of C2 remained with the standard twice-washed cells during the majority of the bactericidal assays reported here.
A fourth wash was introduced in an attempt to remove any remaining activity from the triply-washed cells which had shown minimal bactericidal function in the absence of serum replacement. The fourth supemate contained considerably less C2 activity than the first three. This indicated that the first three washes had removed the major portion of cellassociated C2 and correlated well with the functional results in Fig. 4 .
Effect of C2-deficient serum containing a heatstable opsonin on the bactericidal activity of control neutrophils. During the period ofevaluation, one C2-deficient patient developed a heat-stable opsonin (HSO) in his serum. Experiments were performed to compare this patient's initial serum which was free of HSO and the subsequent serum sample which contained the HSO. At a ratio of 1.25 S. aureus per neutrophil, the presence of HSO corrected the bactericidal activity of twice-washed control PMN with C2-deficient serum (Table IV) . At the 50:1 challenge, control PMN killed twice as many S. aureus with C2-deficient serum which contained HSO as with C2-deficient -serum which lacked HSO (48 vs. 24%); although both values were within the normal range. The results indicate that the HSO overcame the depressed opsonic activity resulting from the absence of C2 in this patient's serum.
Effect of C2 deficiency on bactericidal activity against E. coli. The bactericidal activities of PMN and opsonic effectiveness of sera from normal subjects and a patient (16) with C2-deficiency were compared using E. coli (Table V) . All of the studies were performed with triply-washed PMN, a ratio of 1.25 E. coli per neutrophil, and a final serum con- C2-Deficient serum 92 (6) [NS]-91 (4) II [NS] [NS]
C2-Deficient + purified C2 94 (6) [NS]-88 (4) No serum added 1.2±1.1 (14) [NS]---1.0 (4) (16, 18, 19, (30) (31) (32) . This association of C2 deficiency and recurrent infection does not, however, establish a causal relationship. Because of several factors, including the underlying diseases of the patients (33) , possible compensatory mechanisms such as complement-independent opsonins, surface phagocytosis (34, 35) , and the selective requirement for C2 by only certain bacteria, this point requires further investigation. This will probably involve detailed, prospective study of individual patients and infective organisms isolated from each.
The present findings also demonstrate that alterations in experimental design of in vitro test systems have a significant influence on the results obtained. Modification of the bacteria to neutrophil ratio in these studies produced changes both in absolute levels of bacteria killed and in the proportionate degrees of abnormality produced by the C2 deficiency. With twice-washed control PMN in C2-deficient serum, increasing the bacterial ratio improved the bactericidal activity against S. aureus. In this specific situation a defect was demonstrable at 1.25:1 but not at 50:1. It is not clear from the present experiments at what stage of phagocytosis the condition of minimal opsonization is being compensated for by added bacterial challenge. Increasing the number of bacteria to cell contacts may facilitate attachment via the small amount of cell-associated C2 available. It is also possible that attachment and (or) ingestion of the first few bacteria enhances the intrinsic phagocytic ability of the neutrophil rendering it less dependent upon complement opsonization of the bacteria. This activation phenomenum after the initial ingestion may parallel the enhancement of neutrophil bactericidal capability associated with the second and third bacterial ingestion which has been previously reported (36) .
It was the use of two well-controlled ratios of bacteria which led to the recognition of the importance of trace amounts of serum components remaining on once or twice-washed PMN. In these studies, trace amounts of C2 on the surface of control PMN had a profound influence on bactericidal effectiveness in the face of suboptimal opsonization from the media. The amount of C2 remaining with control PMN progressively decreased as a function of the number of times the cells were washed, and paralleled a declining bactericidal activity in the absence of media opsonins. These findings indicate that the bactericidal action of twice-washed control cells in C2-deficient serum was due to C2 which remained on the cells. Moreover, they emphasize the necessity for awareness of possible residual serum components on surfaces of phagocytes in the design and interpretation of studies of opsonization.
